MarketCapTrends
XFOR
X4 Pharmaceuticals Inc. (XFOR)
NASDAQ · Healthcare

X4 Pharmaceuticals Inc. Long Term Debt 2018–2025

X4 Pharmaceuticals Inc. annual/quarterly long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • X4 Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 75.0M, a 0.00% increase year-over-year.
  • X4 Pharmaceuticals Inc. long term debt for 2025 were 75.0M, a 0.00% increase from 2024.
  • X4 Pharmaceuticals Inc. long term debt for 2024 were 75.0M, a 36.36% increase from 2023.
  • X4 Pharmaceuticals Inc. long term debt for 2023 were 55.0M, a 69.23% increase from 2022.
  • X4 Pharmaceuticals Inc. long term debt for 2022 were 32.5M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
X4 Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $)
2025$75
2024$75
2023$55
2022$33
2021$33
2020$33
2019$20
2018$10
X4 Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $)
2025-12-31$75
2024-12-31$75
2023-12-31$55
2022-12-31$33
2021-12-31$33
2020-12-31$33
2019-12-31$20
2018-12-31$10

X4 Pharmaceuticals Inc. Long Term Debt — FAQ

X4 Pharmaceuticals Inc. (XFOR) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XFOR's long term debt history?

The chart and table above show X4 Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.